Genprex Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2015
Net Income	-27.63	-30.86	-23.74	-20.66	-17.94	-10.65	Upgrade
Depreciation & Amortization	0.01	0.02	0.03	0.02	0.02	0.01	Upgrade
Share-Based Compensation	4.59	5.41	4.73	5.35	4.25	3.53	Upgrade
Other Operating Activities	-0.08	0.7	1.36	1.01	-0.26	0.19	Upgrade
Operating Cash Flow	-23.1	-24.74	-17.62	-14.28	-13.94	-6.92	Upgrade
Capital Expenditures	0	0	0	-0.03	-2.23	-0.84	Upgrade
Other Investing Activities	-0.07	-0.07	-0.06	-0.05	-0.11	-0.11	Upgrade
Investing Cash Flow	-0.07	-0.07	-0.06	-0.08	-2.34	-0.95	Upgrade
Share Issuance / Repurchase	13.31	10.59	0.01	25.68	41.59	1.27	Upgrade
Financing Cash Flow	13.31	10.59	0.01	25.68	41.59	1.27	Upgrade
Net Cash Flow	-9.87	-14.22	-17.67	11.31	25.32	-6.6	Upgrade
Free Cash Flow	-23.1	-24.74	-17.62	-14.32	-16.16	-7.75	Upgrade
Free Cash Flow Per Share	-14.28	-18.09	-14.70	-12.16	-18.20	-19.35	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).